Latest news on ‘Health & Drug’
-
Germany’s Merkel: Euro Helped Euro Zone Through Crisis
HANNOVER, Germany (Dow Jones) – The strength of the euro helped European countries that share the common currency overcome the economic crisis, Germany’s Chancellor Angela Merkel said Monday.
“The euro brought [...] -
CVS Caremark 4Q Profit Rises 10% Amid Revenue Strength
NEW YORK (Dow Jones) – CVS Caremark Corp.’s (CVS) fourth-quarter earnings rose 10% amid stronger sales at its pharmacy businesses while the hybrid drug-store pharmacy benefit manager’s chief executive expressed [...]
-
Pfizer 4Q Net Doubles; Earnings View Below Street
By Peter Loftus
Pfizer Inc.’s (PFE) fourth-quarter earnings more than doubled from a year-earlier profit that was dampened by a legal settlement, while the acquisition of Wyeth helped push sales up [...] -
Boston Scientific To Pay J&J $1.73B To Settle Stent Patent Disputes
By JON KAMP
Boston Scientific Corp. said Monday it would pay Johnson & Johnson a hefty $1.73 billion to end more disputes in long-running legal battles over patents for heart stents.
The [...] -
Health stocks pull market higher as Mass. votes
By Tim Paradis and Ieva M. Augstums, AP Business Writers
NEW YORK (AP) – Investors moved back into stocks on hopes that a special election in Massachusetts will take away power [...] -
Johnson & Johnson Recalls More OTC Drugs Amid Odor Complaints
DJ – Johnson & Johnson’s (JNJ) McNeil Consumer Healthcare unit is again broadening its voluntary recalls of over-the-counter consumer medications amid complaints of a musty, moldy odor. The move closely [...]
-
UTHR Best Biotech Stock For 2010
by Monica Gerson
Analyst Raj Mehra of Auriga USA maintains his “buy” rating on United Therapeutics (NASDAQ: UTHR), while raising his estimates for the company. The target price for UTHR has [...] -
IRIS International (IRIS) Completes Purchase of German and U.K. Business from Distributor
IRIS International, Inc. (NASDAQ: IRIS) announced today that it had completed the purchase at book value of certain assets relating to the current distribution of Iris’ products in the UK [...]
-
Cytori Stock Jumps As Fat-Grafting System Gets FDA Approval
Cytori Therapeutics Inc. (CYTX) said it has gotten approval from the Food and Drug Administration to sell what it calls the first device in the U.S. cleared for using a [...]
-
Teva sees revenue more than doubling by 2015
NEW YORK (Reuters) – Teva Pharmaceutical Industries Ltd (TEVA.TA), the world’s largest generic drugmaker, on Thursday set a target of revenue of $31 billion in 2015, more than double its [...]
